Trophoblastic tumors—prognostic factors
- 15 July 1981
- Vol. 48 (S1) , 602-607
- https://doi.org/10.1002/1097-0142(19810715)48:1+<602::aid-cncr2820481326>3.0.co;2-8
Abstract
No abstract availableThis publication has 46 references indexed in Scilit:
- Anti-tumour activity of the epipodophyllin derivative VP16–213 (etoposide: NSC-141540) in gestational choriocarcinomaPublished by Elsevier ,1980
- A new combination chemotherapy for resistant trophoblastic diseaseGynecologic Oncology, 1979
- RELATIONSHIP OF ORAL CONTRACEPTION TO DEVELOPMENT OF TROPHOBLASTIC TUMOUR AFTER EVACUATION OF A HYDATIDIFORM MOLEBJOG: An International Journal of Obstetrics and Gynaecology, 1976
- HYDATIDIFORM MOLE: TWO ENTITIESThe Lancet, 1976
- Chemotherapy of gestational choriocarcinomaCancer, 1972
- Medical Presentations of ChoriocarcinomaBMJ, 1971
- BIOLOGICAL ASPECTS OF GESTATIONAL NEOPLASMS DERIVED FROM TROPHOBLASTAnnals of the New York Academy of Sciences, 1971
- Pregnancies after Chemotherapy of Trophoblastic NeoplasmsScience, 1970
- Choriocarcinoma after Hydatidiform Mole. Studies Related to Effectiveness of Follow-up Practice after Hydatidiform MoleBMJ, 1969
- THE INFLUENCE OF THE PRIMARY TREATMENT OF HYDATIDIFORM MOLE ONITS SUBSEQUENT COURSE*BJOG: An International Journal of Obstetrics and Gynaecology, 1966